Role of Cys-603 in dimer/oligomer formation of the breast cancer resistance protein BCRP/ABCG2.

Cancer Sci 2005 Dec;96(12):866-72

Division of Molecular Biotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan.

Breast cancer resistance protein (BCRP/ABCG2) is a half-molecule ATP-binding cassette transporter that we have previously suggested might function as a homodimer, bridged by disulfide bonds. In the present study, we carried out cysteine-scanning mutagenesis, substituting Ser for Cys, and established 12 PA317 transfectants expressing BCRP mutants with possible disruptions to their S-S bonds. Western blot analysis of BCRP from the wild-type transfectants (PA/WT) confirmed that the wild-type protein migrates as a 140-kDa dimer under non-reducing conditions, but as a 70-kDa monomer under reducing conditions. However, under non-reducing conditions the BCRP-C603S mutant migrated both as a 70-kDa monomer and a 140-kDa dimer, whereas all other mutant BCRP migrated only as dimers. PA317 cells transfected with C603S-BCRP (PA/C603S) showed either similar or only marginally lower SN-38 resistance than PA/WT cells, despite the reduced levels of BCRP dimer in these cells. Moreover, the degree of SN-38 resistance in the mutant BCRP transfectants was found to be associated with the monomer expression levels under reducing conditions. Reverse transcription-polymerase chain reaction analysis showed that the BCRP mRNA levels were similar in the transfectants. We subsequently generated six C603X mutants of BCRP (X=D, H, R, Y, A and W) and carried out western blot analysis and drug sensitivity assays. The results were equivalent to those from the PA/C603S cells, with some variations that again corresponded to the monomer levels. Our findings suggest that Cys-603 is an important residue in the covalent bridge between BCRP monomers but that a functioning unit of BCRP may not necessarily require covalent linkages.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2005.00126.xDOI Listing
December 2005

Publication Analysis

Top Keywords

bcrp
9
protein bcrp/abcg2
8
resistance protein
8
cancer resistance
8
mutant bcrp
8
analysis bcrp
8
sn-38 resistance
8
western blot
8
breast cancer
8
blot analysis
8
70-kda monomer
8
reducing conditions
8
non-reducing conditions
8
140-kda dimer
8
cells despite
4
despite reduced
4
pa/wt cells
4
lower sn-38
4
conditions 70-kda
4
resistance pa/wt
4

References

(Supplied by CrossRef)

Ueda K et al.
J Biol Chem 1987

Pastan I et al.
Proc Natl Acad Sci USA 1988

Cole SPC et al.
Science 1992

Allikmets R et al.
Cancer Res 1998

Miyake K et al.
Cancer Res 1999

Litman T et al.
J Cell Sci 2000

Allen JD et al.
Cancer Res 1999

Similar Publications